Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_623_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
65 Мб
Скачать
The chest andlungs 135
https://t.me/medicina_free
Clinical features
There is usually a history of the underlying cause. The patient is febrile, toxic and may be anaemic. There are signs of fluid in the chest on the affected side. In chronic cases, finger clubbing may be present.
Special investigations
Full blood count will reveal a leucocytosis. Inflammatory markers are elevated.
Chest X- ray demonstrates an effusion, and there
• may be evidence of the underlying lung disease.
CT scan will demonstrate the anatomy and magni-
• tude of the problem.
Bronchoscopy is useful in determining the primary
pathology.
Aspiration of the chest confirms the diagnosis and
• identifies the responsible bacteria. The infecting organisms are usually Pneumococcus, Streptococcus or Staphylococcus.
Treatment
An acute empyema may respond to drainage together with antibiotic therapy, based on the sensitivity of the responsible organism. Simple drainage with an ade­quately sized chest drain (ideally 28F or larger) may suffice. If this fails, intrapleural fibrinolytic therapy can be considered. If this fails, surgery should be con­sidered. This is usually by VATS, but sometimes thora­cotomy is needed.
After a few weeks, the cavity becomes thick walled and open removal (decortication) is required. The aim is to restore normal lung function.
Lung tumours
Classication
Benign
• Adenoma.
• Hamartoma.
• Haemangioma (rare).
Malignant
1 Primary:
a small- cell lung cancer (SCLC);
b non- small- cell lung cancer (NSCLC) includes
the histological subdivisions of:
squamous cell carcinoma;
adenocarcinoma; large- cell carcinoma.
c
neuroendocrine (carcinoid) tumours.
2
Secondary:
carcinoma (especially breast, kidney);
a b
sarcoma (especially bone);
melanoma.
c
Carcinoid tumours
These are a form of neuroendocrine carcinoma of which there are four types, all of which share the same neural crest origin:
typical carcinoid;
• atypical carcinoid;
• large- cell neuroendocrine carcinoma;
small- cell carcinoma.
Each has particular histological features along a spec­trum from benign to malignant.
Typical carcinoid tumours
Nine out of 10 carcinoid tumours are ‘typical carci­noids’, and tend to follow a very benign course with metastases being rare and most other problems being due to local effects. Carcinoids presenting in central airways typically present with cough and dyspnoea, but rarely haemoptysis. Sometimes, it is thought to be late­mon condition. Any late ‘asthma’ that has no response to bronchodilators should be investigated. If the airway becomes obstructed, secretions can collect distally. These can then become infected and cause pneumonia.
Investigations
Chest X- ray is often normal.
CT scan usually reveals a mass, and evidence of
spread (enlarged lymph nodes, distal metastases).
Biopsy, either at bronchoscopy if a large central
airway, or CT guided if peripheral.
CT- positron emission tomography (CT- PET) scan
and brain imaging if curative resection is planned, to exclude metastases.
onset asthma, which is a com-
136 The chest andlungs
https://t.me/medicina_free
Treatment
A patient who has presented with distal infection due to a proximal obstruction can have the lesion bron­choscopically debrided. The aim of this is to open the airway, relieve obstruction and reduce sepsis prior to definitive resection. Bronchoscopy can be repeated if the patient is too frail to undergo surgery.
Surgery consists of local removal, ensuring com­plete clearance. In central airways, it can almost always be done by lung- preserving techniques such as sleeve resection. Only occasionally is lung resec­tion, such as lobectomy, required.
Lung cancer
This is the second most common cancer affecting men (after prostate) and in women is second only to breast cancer. In the period 2016–2018, there were 49,000new cases per annum, with 35,000 deaths; the predicted long- term (10- year) survival for patients diagnosed in 2018 in England is just 10%. This is improving due to more cases being treated as a con­sequence of increased awareness and earlier presen­tation. When lung cancer is diagnosed early, survival is considerably improved with surgical resection.
The incidence of lung cancer in men has been fall­ing since the late 1970s, reflecting a reduction in smoking. This fall is yet to be seen in women, although the rate of increase is slowing. Nine out of 10 cases occur in people 60 years and older.
Aetiology
In the UK, the main aetiological factor is smoking. Passive smoking; air pollution with diesel, petrol and other volatile hydrocarbon fumes; asbestos exposure; and exposure to radioactive gases such as radon in uranium mines are also predisposing factors. The incidence is higher in urban than in rural popula­tions. There is also a familial element to lung cancer, with a 50% increase in risk if a first- degree relative has it. Although this could be due to similar environmen­tal risks such as smoking, there are also genetic fac­tors. Particular genotypes are associated with worse outcomes and also greater or lesser response to molecular therapy.
Carcinoma of the lung has a poor prognosis, and the gravity of this condition should be impressed on
all patients who are smokers. The decision whether or not to continue smoking depends on the patient, but there is no doubt that the advice should be to stop smoking. There is an increased incidence of lung can­cer even in patients who smoke only a few cigarettes a day, and this danger is greatly increased in patients smoking more than 20 cigarettes a day for a number of years.
Pathology
There are two main types of lung cancer, small-cell and non-small-cell lung cancer.
Macroscopic appearance
About half the tumours arise in the main bronchi (particularly squamous carcinoma), and 75% are vis­ible at bronchoscopy. The growth may arise peripher­ally (particularly adenocarcinoma), and some appear to be multifocal.
The bronchial wall is narrowed and ulcerated. Surrounding lung tissue is invaded by a pale mass of tumour, which may undergo necrosis, haemorrhage or abscess formation. The lung segments distal to the occlusion may show collapse, bronchiectasis or abscess formation.
Microscopic appearance
1 SCLC (15%) (in the past called ‘oat’ cell). The
tumour comprises small cells with little cyto­plasm. It has neuroendocrine properties and can produce molecules giving rise to paraneoplastic syndromes. It has a poor prognosis, has generally spread by the time of diagnosis, and is best treated by chemotherapy and sometimes radiotherapy. It behaves very differently to typical carcinoid tumours.
NSCLC (85%).
2
a Squamous cell carcinoma. Usually occurring in
the main bronchi, it is mostly poorly differenti­ated and arises in an area of squamous meta­plasia of bronchial epithelium.
b Adenocarcinoma. This has glandular features
and can be multifocal. It is the most common NSCLC.
c Large- cell carcinoma. Large cells containing
abundant cytoplasm and without evidence of squamous or glandular differentiation; this is also a rapidly growing cancer.
The chest andlungs 137
https://t.me/medicina_free
Spread
Local: to pleura, left recurrent laryngeal nerve (hoarse voice), phrenic nerve, pericardium, oesophagus (broncho­pathetic chain (Horner’s syndrome plexus (Pancoast’s tumour
Lymphatic: to mediastinal and cervical nodes.
oesophageal fistula), sym-
1
2
at lung apex).
) and brachial
Compression of the superior vena cava by massive mediastinal node involvement produces gross oedema and cyanosis of the face and upper limbs (superior vena cava syndrome).
Blood: to bone, brain, liver and adrenals.
Transpleural: pleural seedlings and effusion.
Clinical features
Carcinoma of the lung often presents late. Early cases are more commonly found at the time of investigation for other problems or by screening. Clinical presenta­tion may be with one or more of the following:
Local features, namely cough, dyspnoea, haemop-
tysis or lung infection. Chest pain suggests spread to pleural surface or a pleural effusion.
Secondaries (metastases), especially likely to occur
• in the brain, adrenal, liver and bones; thus, the patient may present with evidence of a space occupying lesion within the skull, pathological fracture, jaundice and hepatomegaly, or adreno­cortical failure. Skin lesions may also occur and are readily biopsied.
Paraneoplastic syndromes due to the remote
effects of a hormone or cell product produced by the tumour. Small­adrenocorticotrophic hormone (ACTH), while squamous carcinomas may produce parathor­mone (PTH) and present with hypercalcaemia.
General effects of neoplasm: loss of weight,
anaemia, cachexia and endocrine disturbances. Patients may also present with bizarre neuropathies and myopathies.
Unfortunately, by the time lung cancer is diagnosed, most cases are incurable. About half the patients will be found to have inoperable tumours when they have had no symptoms at all, with a lesion discovered on
1
Johann Horner (1831–1886), Professor of Ophthalmology,
Zurich, Switzerland.
2
Henry Pancoast (1875–1939), Professor of Radiology,
University of Pennsylvania, Philadelphia, PA, USA.
cell carcinomas often produce
routine chest X-
ray. Any middle- aged or elderly person presenting with a respiratory infection or cough that has continued for more than 2 weeks should have a chest X­and nothing shows on the chest X-
ray, and if the symptoms persist
ray, a CT scan
should be considered.
On examination, special attention should be paid to evidence of stridor or hoarseness of the voice due to recurrent laryngeal nerve involvement by the can­cer. There may be clubbing of the fingers in addition to nicotine staining. The heart may be invaded, result­ing in atrial fibrillation or a pericardial effusion. There may be enlarged lymph nodes, especially at the root of the neck, and signs in the chest of consolidation, fluid or collapse.
Special investigations
Investigation aims to confirm the presence of a can­cer, and to identify its stage (spread) and histological type.
Chest X- ray may show an opacity in the lung and
enlargement of the hilar lymph nodes. The differential diagnosis of a mediastinal mass on radiological examination of the chest is listed in Box14.1. There may be a raised hemidiaphragm due to paralysis secondary to involvement of the
Box 14.1 Abnormal opacity inthe
mediastinum
Retrosternal thyroid
Aneurysm of the thoracic aorta
Thymic tumour and cysts
Lung cancer with a mediastinal mass
Heart enlargement: cardiac failure, valve incompetence, pericardial effusion, left–right shunts and cardiomyopathies
Enlarged lymph nodes: sarcoid, Hodgkin’s disease, other lymphoma, leukaemia and secondary deposits
Oesophageal enlargement: tumour, hiatus hernia and mega- oesophagus in achalasia of the cardia
Paravertebral abscess, particularly due to tuberculosis
Scoliosis
Dumb- bell tumour of neurofibroma
Dermoid cyst or teratoma
138 The chest andlungs
https://t.me/medicina_free
phrenic nerve. Abnormalities on chest X- ray should prompt a CT scan.
Contrast- enhanced CT scan of the neck, chest and
• upper abdomen, including the whole chest, liver, adrenal glands and neck to base of skull, including the vocal cords, to assess the primary lung lesion and seek evidence of metastatic spread.
PET- CT scan is an invaluable means of both con- firming likely malignancy in peripheral lesions and identifying mediastinal spread. In conjunction with CT, it also permits diagnosis of, for instance, adrenal adenomas mimicking metastases.
Bronchoscopy and biopsy. Bronchoscopy may reveal an ulcerating or exuberant growth, and involved lymph nodes may widen the carina. Brushings and washings may be taken for cytology in addition to biopsy of a visible tumour.
Percutaneous needle biopsy of a peripherally
placed lesion under imaging guidance.
Endobronchial/endo- oesophageal ultrasound guided
biopsy. Mediastinal lymph nodes can be sampled. Mediastinal spread is usually a contraindication to primary surgery.
Mediastinoscopy, performed through a small suprasternal incision, may be indicated to remove lymph nodes from the region of the carina for his­tological examination to aid in staging. VATS may also be helpful.
Pulmonary function tests to determine lung reserve and, hence, the capacity to withstand sur­gery. Chronic obstructive pulmonary disease is common in this patient group. Patients with a forced expiratory volume in 1 second (FEV can usually tolerate pneumonectomy (removal of the whole lung); those with an FEV ally tolerate lobectomy (removal of one lobe of the lung). This should be coupled with a test of alveo­lar function (gas transfer), and in surgical candi­dates, a prediction of remaining function with a perfusion scan. Patients with impaired fitness must be carefully assessed to determine if surgery is appropriate.
) >2.0L
1
>1L can usu-
1
Treatment
Surgery
Patient treatment will be determined in an MDT meeting. Surgery is undertaken in a subset of patients with sufficient respiratory reserve who have disease localized to one lobe or lung (T1, T2
tumours, and sometimes T3 and rarely T4) but with only intra­thy. Mediastinal (N2) or more distal lymph node involvement is a marker of poorer prognosis, so generally such patients do not undergo resection. Sometimes, such patients will undergo induction treatment with chemotherapy and in selected cases radiotherapy to downstage the tumour before sur­gery. There is emerging evidence that molecular therapies can also downstage cancers, rendering them suitable for surgery.
The aim of surgery is complete resection of the tumour and the related local lymph nodes, together with extensive sampling of other ipsilateral mediastinal node stations. For many patients, this will require lobectomy with a mortality risk of 1–2%. Pneumonectomy is now performed relatively rarely – it is a major physiological insult, with a mortality risk of at least 4%.
When lung cancer is diagnosed early, survival is considerably improved with surgical resection. A patient with Stage 1NSCLC (less than 4cm, no nodal spread) that has been completely resected by lobec­tomy has at least a 60% five- year survival and in some groups even better. There is increasing interest in lesser lung resections (sub­ticularly with smaller peripheral lesions. The out­comes of these resections appear similar to radical radiotherapy.
The majority of lung cancer resections in some countries, including the UK, are now performed by minimally invasive VATS, as long as appropriate oncological principles of surgical margin, gentle tis­sue handling and complete node clearance are adhered to. For patients with small tumours and lim­ited reserve, segmental resections, following anatomi- cal borders, give good long-
pulmonary or hilar (N1) lymphadenopa-
lobar resections), par-
term results.
Radiotherapy
Radiotherapy can be used with curative or palliative intent. In all such cases, there is careful assessment of the case by an oncologist who will determine a treat­ment plan. Radiotherapy may give useful palliation for inoperable cases. Although it may not prolong life, it may stop distressing haemoptysis, relieve the pain from bone secondaries and produce dramatic improvement in a patient with acute superior vena cava obstruction. It may also give some relief from the irritating cough and dyspnoea resulting from early bronchial obstruction.
Chemotherapy
https://t.me/medicina_free
Cyclical cytotoxic therapy combined with radiother­apy is the treatment of choice for small­Chemotherapy is also used in the adjuvant setting
surgery) if high- risk features are identified. This
(post­includes the presence of lymph node involvement. Sometimes, chemotherapy is used pre­‘downstage’ tumours, with the aim of increasing the chance of successful surgery.
cell tumours.
operatively to
Targeted chemotherapy
Cancer specimens undergo sequencing to search for genetic mutations, usually involving pathways caus­ing increased cell proliferation. These mutations are targets susceptible to particular inhibitors:
Epidermal growth factor receptor (EGFR) muta-
tions, targeted by gefitinib and afatinib, for example.
Anaplastic lymphoma kinase (ALK), a tyrosine
kinase. Mutation present in 5% of NSCLC, and is blocked by crizotinib and ceritinib, for example.
ROS1, a tyrosine kinase similar to ALK.
• K- RAS gene, targeted by sotorasib.
The chest andlungs 139
Secondary tumours
The lung is second only to the liver as the site of metas­tases, which may be from carcinoma (especially breast, kidney and colorectal), sarcoma (especially bone) or melanoma. Spread may be as a result of either vascular deposits or lymphatic permeation from involved mediastinal nodes– lymphangitis carcinomatosa.
Pulmonary metastases are so common that it should be routine practice to image the chest by CT scan in every case of malignant disease to aid staging the primary cancer.
A low volume of metastatic disease to the chest may be treated by surgical excision, radiotherapy or radi­ofrequency ablation.
Additional resources
Case 19: A patient with a chest drain Case 20: A fatal lung disease
15
https://t.me/medicina_free
15
Venous disorders ofthe lower limb
Manj Gohel
Learning objectives
To understand the normal anatomy and physiology of the venous
system.
To know the causes and treatment of supercial and deep venous
insuciency of the lower limb.
Normal venous function
The venous system of the legs returns deoxygenated blood from the peripheries to the right heart via a network of low­Flow in the correct direction is maintained by a series of unidirectional valves in the peripheral veins, and flow is driven by muscle pumps, predominantly in the calf but also in the feet. As the calf and foot mus­cles contract, the deep veins within them are com­pressed and emptied, the blood passing upwards, directed towards the heart by the non­As the muscles relax, blood flows in from the superfi­cial system via perforators, as well as from more dis­tal segments of the vein, only to be forced upwards again by the next contraction of the calf muscles, which thus act as a pump.
Ellis and Calne’s Lecture Notes in General Surgery, Fourteenth Edition. Edited by Christopher Watson and Justin Davies. © 2023 John Wiley & Sons Ltd. Published 2023 by John Wiley & Sons Ltd. Companion website: www.wiley.com/go/Watson/GeneralSurgery14
resistance superficial and deep veins.
return valves.
Anatomy ofthe venous drainage ofthe lower limb
To understand venous disease in the leg, it is essential to understand the functional anatomy of the venous system. The venous system consists of a complex net­work of superficial veins, deep veins and perforating veins (Figure15.1). Most of the venous flow is in the deep veins (around 90%), but both superficial and deep veins can cause disease.
The deep venous system
The deep veins of the leg usually accompany (and share the name of) the main arteries of the lower limb and are located deep to the fascia that envelops the muscular compartments. Crural veins in the calf (anterior tibial, posterior tibial and peroneal veins) drain into the popliteal vein behind the knee, which ascends as the femoral vein, becoming the common femoral vein in the groin and then the external iliac vein above the inguinal ligament. From there, blood flows up the common iliac vein, via the inferior vena cava, to the right atrium.
Deep
https://t.me/medicina_free
fascia
malleolus
Valve at sapheno-
femoral junction
Great saphenous vein
Mid-thigh perforator
Femoral vein
Small saphenous vein
Ankle perforatorsLateral
Venous disorders ofthe lower limb 141
veins (particularly the anterior accessory saphenous vein, in the territory of the great saphenous vein). These veins are located superficial to the deep fascia and drain the skin and superficial tissues.
Perforating veins
In addition to the saphenofemoral and saphenopo­pliteal junctions, there are numerous additional communications between superficial and deep veins. These are called perforating veins, or ‘perfora­tors’, as they typically pierce the fascia to reach the deep veins. Although the anatomy of perforators is notoriously variable, there is typically a mid­perforator (called the Hunterian perforator on account of its relationship to Hunter’s canal several calf perforators located on the medial aspect of the tibia from the ankle to the knee.
thigh
1
), and
Aetiology ofvenous disease
The aetiology of venous disease may be classified as follows:
• Congenital;
• Primary, the most common;
• Secondary (post- thrombotic);
• Idiopathic, where no venous cause for disease is
identified.
Figure15.1 The venous system of the leg. Note that
there are two main supercial veins, the great saphenous and small saphenous veins, each of which drains into the deep veins, at the saphenofemoral and saphenopopliteal junctions, respectively, but also via several perforating veins.
The supercial venous system
This comprises the medially placed great (long) saphenous vein, draining from the dorsum of the foot to the saphenofemoral junction in the groin, and the small (short) saphenous vein, which drains the lateral aspect of the lower limb into the popliteal vein behind the knee. There may also be accessory saphenous
Primary venous disease
The underlying cause of venous disease is chronic venous hypertension. Persistent high pressure in the venous system of the leg can result in symptoms, clinical manifestations and complications of venous disease. A common cause of venous hypertension is damage or failure of the vein valves in superficial or deep veins, which can result in blood flow away from the heart, termed ‘reflux’ or ‘incompetence’ (Figure 15.2). The causes of valve incompetence are poorly understood, but there are likely to be genetic and acquired factors.
When trying to understand the development of vari­cose veins, some scientists favour the ‘descending’ theory, where superficial vein valve failure starts at the junctions and progresses down the leg. Alternatively,
1
John Hunter (1728–1793), Surgeon, St George’s Hospital,
London, UK.
142 Venous disorders ofthe lower limb
https://t.me/medicina_free
Increased
pressure
Competent
the ‘ascending’ theory suggests that varicose veins start distally and progress up the leg, and this is supported by the observation that varicose veins often exist with a competent saphenous junction. The development of varicose veins is likely to be multifactorial.
It was previously thought that superficial vein reflux causes only varicose veins, whereas venous skin changes and ulceration were caused by deep venous disease. Our understanding of venous pathophysiol­ogy has evolved, and it is now widely accepted that superficial venous reflux alone can (and often does) result in oedema, venous skin changes and ulcera­tion. While the precise pathophysiological mecha­nisms linking venous hypertension and skin damage are debated, high capillary hydrostatic pressure results in diffusion of fluid, red cells and white cells into the soft tissues, resulting in chronic inflammation and skin changes.
incompetence
Incompetent
Congenital venous disease
Dilated veins may be seen as part of a number of inherited syndromes, such as Klippel–Trenaunay syn-
2
drome
. The syndrome involves three elements: mul­tiple congenital venous malformations producing varicose veins, hypertrophy of bones and soft tissues and extensive cutaneous haemangiomas. It usually affects the lower limbs.
2
Maurice Klippel (1858–1942), Neurologist, Salpêtrière
Hospital, Paris, France. Paul Trenaunay (b.1875), Neurologist.
Valvular
Figure15.2 Normal veins and
incompetent varicose veins. Note that the vein dilates under pressure and the valve becomes incompetent.
Secondary (post- thrombotic) venous disease
Previous deep vein thrombosis may result in chronic changes and damage to the vein, resulting in venous hypertension. There are several contributing factors:
Deep vein reflux, secondary to valvular damage and inability to maintain the one- way flow after thrombosis.
Scarring of deep veins, remodelling the vein wall.
Venous obstruction may cause additional pressure on competent vein valves (in deep and superficial veins), causing further valve failure and com­pounding the clinical picture. There is a tendency for the condition to get worse as further valves are involved.
Tortuous, dilated veins may also be seen in patients with deep vein obstruction. These are important col­lateral veins providing an alternative route for venous return to the heart and should not be confused with varicose veins.
Clinical presentation
Patients with venous disease may seek help for a wide variety of reasons, including symptoms, complica­tions or cosmetic concerns (or any combination of these). Typical symptoms include aching, throbbing or heaviness/tiredness in the legs as well as swelling of the ankles, particularly after long periods of
Venous disorders ofthe lower limb 143
https://t.me/medicina_free
standing. Patients with superficial or deep venous disorders may present with a range of overlapping symptoms and clinical signs. The CEAP classifica-
3
tion
is the most widely accepted.
Thread veins / reticular veins
Also referred to as ‘spider veins’, or telangectasia, these are very small, superficial veins that can cause cosmetic concern. Treatment is not usually offered in public healthcare systems.
Leg swelling andskin changes
Peripheral oedema is a common manifestation of chronic venous disease, as the increased hydrostatic forces (Starling’s forces
4
) result in increased volumes of interstitial fluid that the lymphatic system is unable to drain. Oedema may only affect the ankle after pro­longed standing, but constant and extensive swelling may also be seen.
Often occurring on the medial lower calf (the medial gaiter area), there are several skin manifestations that are associated with venous disease, including:
Haemosiderinosis and pigmentation: extravasation
of red blood cells, which become deposited as hae­mosiderin in the skin and subcutaneous tissues.
Venous eczema / stasis dermatitis: a common early
skin complaint, characterized by dry, itchy and scaly skin.
Lipodermatosclerosis: thickening and fibrosis of the
skin and soft tissues, resulting in the ‘inverted cham- pagne bottle’ appearance, which occurs due to chronic inflammation secondary to venous hypertension.
Venous ulceration
A chronic leg ulcer is defined as a defect in the skin of the lower leg, remaining unhealed for more than 4 weeks. Chronic venous hypertension accounts for the vast majority of chronic leg ulcers and is recog­nized as an enormous cause of patient distress and health service resource use worldwide. Ulcers are usually superficial, can be very painful, and may start with minor trauma or without any obvious precipi­tant. Ulceration is considered the most extreme
3
Clinical, Etiological, Anatomical and Pathophysiological
(CEAP) classication of venous disorders.
4
Sir Ernest Starling (1866–1927), Professor of Physiology,
University College, London, UK.
presentation in the spectrum of venous disorders and patients usually have other signs of venous disease such as skin changes, varicose veins or oedema.
Venous ulcers either have an edge, which is ragged, or where the ulcer is healing, the margins will be shelving with a faint blue rim of advancing ep ithelium. Previous scarring appears as a white rim around the ulcer, known as atrophie blanche. Rarely, a squamous carcinoma can develop in the edge of a long­ulcer (Marjolin’s ulcer
5
). Approximately 90% of all
standing
ulcers of the legs are venous in origin, but other, rarer, causes should always be considered (Box15.1).
Other complications ofvaricose veins
In addition to the clinical presentations described above, patients may also present with specific com­plications of varicose veins.
1
Bleeding. Prominent, superficial dilated veins may
bleed profusely if knocked. The high venous pressure in the incompetent vein can result in
Box 15.1 Differential diagnosis ofleg ulcers
Chronic venous ulcer due to venous hypertension.
Ischaemic ulcer due to impaired arterial blood supply; the peripheral pulses must always be examined and ankle- brachial pressure indexes checked.
Mixed ulcers, with ischaemic and venous contributions.
Neuropathic ulcer, particularly common in diabetics where they are often compounded by ischaemia due to diabetic microangiopathy.
Malignant ulcer, a basal cell carcinoma, or a squamous carcinoma (possibly arising in a pre- existing chronic venous ulcer) or an ulcerated malignant melanoma.
Ulcer complicating systemic disease, for example, acholuric jaundice, ulcerative colitis and rheumatoid arthritis.
Repetitive self- inflicted injury (factitious ulceration).
5
Jean Nicholas Marjolin (1780–1850), Surgeon, Hôpital
Sainte- Eugènie, Paris, France
144 Venous disorders ofthe lower limb
https://t.me/medicina_free
life- threatening haemorrhage, particularly in elderly or frail patients who may be unable to apply pressure and elevate the leg.
2
Superficial vein thrombosis (SVT). Formally
referred to as ‘thrombophlebitis’ or ‘phlebitis’, SVT is a common clinical condition presenting as a hard, red, painful and engorged superficial vein. Virtually, all cases occur in patients with pre­existing varicose veins. Up to a quarter of patients presenting with SVT also have a co­vein thrombosis, indicating that there is likely to be a prothrombotic tendency in these patients.
existent deep
Assessment ofthe patient withvenous disease
History
A detailed history should include information about the presenting symptoms (including the severity and impact on the patient’s quality of life). Patients should be specifically asked about the presence of skin dis­colouration or eczema and the current or past pres­ence of leg ulcers. Other points to note are a history of deep vein thrombosis, or a history suggestive of thrombosis such as swelling and pain postopera­tively, during pregnancy or after a long period of immobilization. Risk factors for venous thromboem­bolism (such as obesity, use of oestrogen­medication or thrombophilia) are important to ascer­tain, as this may direct the thromboprophylaxis plan after any intervention. Previous venous interventions should also be recorded as redo procedures are likely to be associated with greater risks.
Clinical examination
A patient with venous disease should be examined while standing, and the presence/extent of varicose veins should be carefully recorded. Photographic documentation may be of value. Examination of the legs should include inspection of the medial gaiter area for evidence of venous skin changes (eczema, haemosiderosis, lipodermatosclerosis and/or ulcera­tion). The presence of scars should be noted. The arterial status of the leg (presence of peripheral pulses) should also be recorded.
A saphena varix, a prominent dilation of the great
saphenous vein at the saphenofemoral junction, may
containing
be present. It gives a characteristic thrill to the exam­ining fingers when the patient coughs, quite different from a femoral hernia. It disappears when the patient lies flat.
A handheld Doppler assessment can help identify venous incompetence in large or small saphenous veins but has also become largely obsolete due to the widespread availability of colour duplex ultrasound scanning
Special investigations
The aim of any venous investigations is to identify potentially treatable superficial or deep venous disease:
Duplex scan
which is non- invasive, painless and can accurately map the superficial and deep veins in the leg to diagnose both valvular and perforator incompe­tence and deep venous occlusion. Guidelines sug­gest it should be performed before any venous intervention.
Ankle- brachial pressure index, using a handheld
Doppler, to assess the arterial supply to the leg in cases of ulceration and thus determine the appro­priateness of compression therapy.
Cross- sectional imaging (CT or MR) may be
needed to assess proximal deep veins in the abdo­men and pelvis.
Venography and intravascular ultrasound may
also be required to assess venous anatomy in some circumstances.
6
: The ‘gold- standard’ investigation,
Treatment ofvenous disease
The main principle of management for patients with venous disease is to reduce venous hypertension, ideally by treating the underlying cause, in order to improve quality of life. Where it is not feasible or desirable to try and address the underlying superfi­cial or deep venous problem, there are several general measures that may be used. Bed rest and leg
6
Duplex is a combination of grey- scale ultrasound looking at physical structures and colour Doppler looking at ow in vessels. Doppler is named after Christian Doppler (1803–1853), an Austrian Physicist.